MENU
OCT 29 - 30 2014

Cancer: Research, Discovery and Therapeutics Virtual Event Series 2014

This event is now apart of the Cancer Research & Immuno-Oncology Week Virtual Event Series. 

Welcome to the 2nd Annual Event in the Cancer: Research, Discovery and Therapeutics Virtual Event Series!

BioConference Live makes it easier and more cost-effective for the cancer research community to come together online through live video webcasts and real-time networking. BioConference Live attendees learn new concepts, tools and techniques that they can apply to research and diagnosis. BioConference Live requires no travel or time away from the lab or hospital, yet delivers all the benefits of a physical conference. Attendees can earn free CME and CE Credits.

Topics will include Drug Discovery, Clinical Proteomics, Molecular Profiling, Cancer Metabolism: Nutrition and Cancer, Cancer Epigenetics, Therapeutics, Novel trends in cancer detection and screening, Immunotherapy/Harnessing the Immune System for Cancer Therapy, Noninvasive molecular screening for colon cancer, Biomarkers in prostate and bladder cancer, Animal mouse models, Cell signaling, Resistance due to mutations, Kinome profiling, Individualized patient diagnostics, Cancer Therapies & new techniques, Diagnostic testing for clinical decision, Best practices for pregnancy testing prior to cancer therapy, Lactogenic anemia and diagnostic testing: tools for blood conservation in cancer patients and other frail patient, High Dose IL-2 -curative therapy for Metastatic Renal Cell Carcinoma, and other topics.

This event will bring together research scientists, post docs, principal investigators, lab directors and professionals from around the world to learn about recent advances in cancer research. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.

Conference participants will be able to
 

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Chat live with peers and speakers
  • Browse a virtual exhibit floor for solution providers


No crowded airports, delayed flights or expensive hotel rooms, but still the look and feel of a first-rate conference with world renowned experts. Participants also benefit from the fact that experts and vendors are more accessible, no more waiting in line to speak to someone. Think it is too good to be true? Checkout the venue and become a believer.


Speakers
  • Kenneth Buetow, PhD, FACMI

    Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
    BIOGRAPHY
  • Darran O'Connor, PhD

    Senior Lecturer, School of Biomolecular & Biomedical Science, Co-Director, Cancer Biology & Therapeutics Laboratory, University of Dublin
    BIOGRAPHY
  • Nicola Normanno, MD

    Director, Research Department, Centro di Ricerche Oncologiche di Mercogliano, Naples, Italy
    BIOGRAPHY
  • Paul W. Dempsey, PhD

    Chief Science Officer, Cynvenio
    BIOGRAPHY
  • John Carpten, PhD

    Deputy Director of Basic Science, Professor and Director Integrated Cancer Genomics Division, TGen
    BIOGRAPHY
  • Josip Blonder, MD

    Senior Scientist, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research (FNLCR)
    BIOGRAPHY
  • Kristin Landis-Piwowar, PhD, MLS

    Assistant Professor, Biomedical Diagnostic & Therapeutic Sciences, , Oakland University
    BIOGRAPHY
  • Julian J. Lum, PhD

    Scientist BC Cancer Agency's Deeley Research Centre, Assistant Professor Department of Biochemistry and Microbiology, University of Victoria
    BIOGRAPHY
  • Christian Metallo, PhD

    Principal Investigator, Metallo Lab, Assistant Professor, Bioengineering, University of California, San Diego
    BIOGRAPHY
  • Naomi Thomson

    Director, Clinical Analytics and Workflow Products, CLC Bio, a Qiagen company
    BIOGRAPHY
  • Kimberly Kelly , PhD

    Associate Professor of Biomedical Engineering, University of Virginia
    BIOGRAPHY
  • Ruth Nussinov, PhD

    Head, Computational Structural Biology Group, Senior Investigator, Center for Cancer Research, National Cancer Institute
    BIOGRAPHY
  • William Clarke, PhD, MBA, DABCC

    Associate Professor of Pathology, Clinical Toxicology, Director, Point-of-Care Testing, Johns Hopkins University School of Medicine
    BIOGRAPHY
  • Sharon M. Geaghan, MD

    Chief, Pathology at Lucile Packard Children's Hospital at Stanford, Associate Professor in the Department of Pathology, Stanford University
    BIOGRAPHY
  • William M. Gallagher, BSc PhD CBiol MSB

    Chief Scientific Officer at OncoMark, Professor of Cancer Biology, University of Dublin
    BIOGRAPHY
  • Jennifer Stone, PhD

    Senior Market Manager, Oncology , Illumina
    BIOGRAPHY
  • Adrienne C. Scheck, PhD

    Associate Professor, Neuro-Oncology Research, Barrow Brain Tumor Research Center, Barrow Neurological Institute
    BIOGRAPHY
  • Srinivas (Sri) Sridhar, PhD

    Director, NSF IGERT Nanomedicine Science and Technology Program, Director, Electronic Materials Research Institute, Arts and Sciences Distinguished Professor of Physics, Lecturer on Radiation
    BIOGRAPHY
  • Katherine LB Borden, PhD

    Principal Investigator, Structure and Function of the Cell Nucleus research unit, Full Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Instit
    BIOGRAPHY
  • Jonathan Shaffer, PhD, MBA

    Director, R&D, NGS Assay Technologies, QIAGEN
    BIOGRAPHY
  • Fraser Hof, PhD

    Associate Professor, University of Victoria
    BIOGRAPHY
  • Liza Makowski, PhD

    Assistant Professor, Nutrition, UNC Gillings School of Global Public Health
    BIOGRAPHY
  • Mei Kong, PhD

    Assistant Professor, Cancer Biology , City of Hope National Medical Center
    BIOGRAPHY
  • Kelli Bramlett, M.S.

    Research & Development Scientist, Thermo Fisher Scientific
    BIOGRAPHY
  • Vikram Devgan, PhD, MBA

    Senior Director, Spatial Genomics Business Unit, NanoString Technologies
    BIOGRAPHY
  • Anna Barker, PhD

    Co-Director, Complex Adaptive Systems Initiative, Director, Transformative Healthcare Networks, Professor, School of Life Sciences, Arizona State University (ASU)
    BIOGRAPHY
  • Michael MacCoss, PhD

    Professor of Genome Sciences, University of Washington, School of Medicine
    BIOGRAPHY
  • Walter Ausserer, PhD

    Business Unit Management, Senior Business Unit Manager, The Jackson Laboratory
    BIOGRAPHY
  • Peter Blume-Jensen, MD, PhD

    Chief Scientific Officer, XTuit Pharmaceuticals, Inc.
    BIOGRAPHY
  • Michael J Mann, MD

    Associate Professor of Surgery, Division of Adult Cardiothoracic Surgery, Chief of General Thoracic Surgery, University of California, San Francisco, VA Medical Center
    BIOGRAPHY
  • Kerri Phillips

    Clinical Research Product Manager, DNASTAR
    BIOGRAPHY
  • Nadya Tarasova, PhD

    Head, Synthetic Biologics Core, Cancer and Inflammation Program, Center for Cancer Research National Cancer Institute
    BIOGRAPHY

You May Also Like

Agenda

  • OCT 30, 2014 3:00 PM PDT

    Clinical Shotgun Proteomics in Cancer Biomarker and Drug Target Research/Discovery

    Josip Blonder, MD
    Senior Scientist, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research (FNLCR)
    BIOGRAPHY
  • OCT 30, 2014 3:00 PM PDT

    Probing cancer metabolism using isotope tracers to identify therapeutic targets

    Christian Metallo, PhD
    Principal Investigator, Metallo Lab, Assistant Professor, Bioengineering, University of California, San Diego
    BIOGRAPHY
  • OCT 30, 2014 1:30 PM PDT

    Dissecting cancer signaling pathways with chemical scalpels

    Nadya Tarasova, PhD
    Head, Synthetic Biologics Core, Cancer and Inflammation Program, Center for Cancer Research National Cancer Institute
    BIOGRAPHY
  • OCT 30, 2014 1:30 PM PDT

    Structural Pathways of Cancer

    Ruth Nussinov, PhD
    Head, Computational Structural Biology Group, Senior Investigator, Center for Cancer Research, National Cancer Institute
    BIOGRAPHY
  • OCT 30, 2014 12:00 PM PDT

    Breast-Predict: Leveraging the Power of Systems Medicine Towards Personalized Cancer Therapy

    William M. Gallagher, BSc PhD CBiol MSB
    Chief Scientific Officer at OncoMark, Professor of Cancer Biology, University of Dublin
    BIOGRAPHY
  • OCT 30, 2014 12:00 PM PDT

    The metabolic microenvironment in tumors and its impact on T-cell mediated immunity

    Julian J. Lum, PhD
    Scientist BC Cancer Agency's Deeley Research Centre, Assistant Professor Department of Biochemistry and Microbiology, University of Victoria
    BIOGRAPHY
  • OCT 30, 2014 12:00 PM PDT

    What is best practice for testing for unexpected pregnancy in pediatric and adult patients prior to cancer diagnostics, imaging and therapy?

    Sharon M. Geaghan, MD
    Chief, Pathology at Lucile Packard Children's Hospital at Stanford, Associate Professor in the Department of Pathology, Stanford University
    BIOGRAPHY
  • OCT 30, 2014 10:30 AM PDT

    Development of molecularly targeted imaging agents and identification of novel targets in cancer

    Kimberly Kelly , PhD
    Associate Professor of Biomedical Engineering, University of Virginia
    BIOGRAPHY
  • OCT 30, 2014 10:30 AM PDT

    Genomics in the Clinic: Promises and Challenges

    John Carpten, PhD
    Deputy Director of Basic Science, Professor and Director Integrated Cancer Genomics Division, TGen
    BIOGRAPHY
  • OCT 30, 2014 10:30 AM PDT

    Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy: A Tool for Optimizing Drug Management

    William Clarke, PhD, MBA, DABCC
    Associate Professor of Pathology, Clinical Toxicology, Director, Point-of-Care Testing, Johns Hopkins University School of Medicine
    BIOGRAPHY
  • OCT 30, 2014 9:00 AM PDT

    A head-to-head comparison of whole blood derived samples (cfDNA vs CTC DNA) for cancer research using next-generation sequencing

    Paul W. Dempsey, PhD
    Chief Science Officer, Cynvenio
    BIOGRAPHY
  • OCT 30, 2014 7:30 AM PDT

    Challenges in biomarker testing in non-small cell lung cancer research

    Nicola Normanno, MD
    Director, Research Department, Centro di Ricerche Oncologiche di Mercogliano, Naples, Italy
    BIOGRAPHY
  • OCT 30, 2014 6:00 AM PDT

    A platform for combining the results of WES and RNA-seq analysis

    Naomi Thomson
    Director, Clinical Analytics and Workflow Products, CLC Bio, a Qiagen company
    BIOGRAPHY
  • OCT 30, 2014 6:00 AM PDT

    Epigenetic Dysregulation in the Pathogenesis of Myeloproliferative Neoplasms

    Kristin Landis-Piwowar, PhD, MLS
    Assistant Professor, Biomedical Diagnostic & Therapeutic Sciences, , Oakland University
    BIOGRAPHY
  • Drug-tailored, efficacy-predictive and prognostic biomarker approaches for proper patient selection
    OCT 29, 2014 3:00 PM PDT

    Drug-tailored, efficacy-predictive and prognostic biomarker approaches for proper patient selection

    Peter Blume-Jensen, MD, PhD
    Chief Scientific Officer, XTuit Pharmaceuticals, Inc.
    BIOGRAPHY
  • OCT 29, 2014 3:00 PM PDT

    Molecular Prognosis in the Management of Early Stage Lung Cancer

    Michael J Mann, MD
    Associate Professor of Surgery, Division of Adult Cardiothoracic Surgery, Chief of General Thoracic Surgery, University of California, San Francisco, VA Medical Center
    BIOGRAPHY
  • OCT 29, 2014 3:00 PM PDT

    Transforming the future of oncology with genomics

    Jennifer Stone, PhD
    Senior Market Manager, Oncology , Illumina
    BIOGRAPHY
  • OCT 29, 2014 1:30 PM PDT

    Metabolic therapy for the adjuvant treatment of malignant brain tumors

    Adrienne C. Scheck, PhD
    Associate Professor, Neuro-Oncology Research, Barrow Brain Tumor Research Center, Barrow Neurological Institute
    BIOGRAPHY
  • OCT 29, 2014 1:30 PM PDT

    PDX Tumor Models for Oncology Research and Preclinical Prediction

    Walter Ausserer, PhD
    Business Unit Management, Senior Business Unit Manager, The Jackson Laboratory
    BIOGRAPHY
  • OCT 29, 2014 1:30 PM PDT

    Protein phosphatase 2A in cell survival upon metabolic stress

    Mei Kong, PhD
    Assistant Professor, Cancer Biology , City of Hope National Medical Center
    BIOGRAPHY
  • OCT 29, 2014 12:00 PM PDT

    A Next-Gen Sequencing Software Workflow for Cancer Gene Panel Analysis

    Kerri Phillips
    Clinical Research Product Manager, DNASTAR
    BIOGRAPHY
  • OCT 29, 2014 12:00 PM PDT

    Improving the Robustness and Reproducibility of Quantitative Proteomics

    Michael MacCoss, PhD
    Professor of Genome Sciences, University of Washington, School of Medicine
    BIOGRAPHY
  • OCT 29, 2014 12:00 PM PDT

    Obesity, weight loss, and the microenvironment in basal-like breast cancer

    Liza Makowski, PhD
    Assistant Professor, Nutrition, UNC Gillings School of Global Public Health
    BIOGRAPHY
  • OCT 29, 2014 10:30 AM PDT

    Learning from the Pointillists - Using Big Data Approaches to Embrace the Complexity of Cancer

    Kenneth Buetow, PhD, FACMI
    Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
    BIOGRAPHY
  • OCT 29, 2014 9:00 AM PDT

    Reading and disrupting the histone code with chemical agents: making new tools to understand epigenetic methylation pathways in stem-like cancers

    Fraser Hof, PhD
    Associate Professor, University of Victoria
    BIOGRAPHY
  • OCT 29, 2014 9:00 AM PDT

    What's wrong with biomarker development for cancer

    Anna Barker, PhD
    Co-Director, Complex Adaptive Systems Initiative, Director, Transformative Healthcare Networks, Professor, School of Life Sciences, Arizona State University (ASU)
    BIOGRAPHY
  • OCT 29, 2014 9:00 AM PDT

    miRNA Biomarker Discovery: Technologies, workflows, and data analysis solutions for discovering your unique signature

    Jonathan Shaffer, PhD, MBA
    Director, R&D, NGS Assay Technologies, QIAGEN
    BIOGRAPHY
  • OCT 29, 2014 7:30 AM PDT

    Antibody-based Proteomics: Fast-Tracking Molecular Diagnostics and Target Discovery in Oncology

    Darran O'Connor, PhD
    Senior Lecturer, School of Biomolecular & Biomedical Science, Co-Director, Cancer Biology & Therapeutics Laboratory, University of Dublin
    BIOGRAPHY
  • OCT 29, 2014 7:30 AM PDT

    Making Clinical NGS possible

    Vikram Devgan, PhD, MBA
    Senior Director, Spatial Genomics Business Unit, NanoString Technologies
    BIOGRAPHY
  • OCT 29, 2014 7:30 AM PDT

    Targeting the oncogene eIF4E in leukemia reveals a new form of drug resistance

    Katherine LB Borden, PhD
    Principal Investigator, Structure and Function of the Cell Nucleus research unit, Full Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Instit
    BIOGRAPHY
  • OCT 29, 2014 6:00 AM PDT

    Expanding the scope of RNA-Seq to archival FFPE samples

    Kelli Bramlett, M.S.
    Research & Development Scientist, Thermo Fisher Scientific
    BIOGRAPHY
  • OCT 29, 2014 6:00 AM PDT

    Nanotechnologies for Precision Medicine

    Srinivas (Sri) Sridhar, PhD
    Director, NSF IGERT Nanomedicine Science and Technology Program, Director, Electronic Materials Research Institute, Arts and Sciences Distinguished Professor of Physics, Lecturer on Radiation
    BIOGRAPHY
  • Drug Discovery
  • OCT 29, 2014 6:00 AM PDT

    Nanotechnologies for Precision Medicine

    Srinivas (Sri) Sridhar, PhD
    Director, NSF IGERT Nanomedicine Science and Technology Program, Director, Electronic Materials Research Institute, Arts and Sciences Distinguished Professor of Physics, Lecturer on Radiation
    BIOGRAPHY
  • OCT 29, 2014 7:30 AM PDT

    Targeting the oncogene eIF4E in leukemia reveals a new form of drug resistance

    Katherine LB Borden, PhD
    Principal Investigator, Structure and Function of the Cell Nucleus research unit, Full Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Instit
    BIOGRAPHY
  • OCT 29, 2014 9:00 AM PDT

    miRNA Biomarker Discovery: Technologies, workflows, and data analysis solutions for discovering your unique signature

    Jonathan Shaffer, PhD, MBA
    Director, R&D, NGS Assay Technologies, QIAGEN
    BIOGRAPHY
  • OCT 30, 2014 10:30 AM PDT

    Genomics in the Clinic: Promises and Challenges

    John Carpten, PhD
    Deputy Director of Basic Science, Professor and Director Integrated Cancer Genomics Division, TGen
    BIOGRAPHY
  • OCT 30, 2014 3:00 PM PDT

    Clinical Shotgun Proteomics in Cancer Biomarker and Drug Target Research/Discovery

    Josip Blonder, MD
    Senior Scientist, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research (FNLCR)
    BIOGRAPHY
  • Molecular Profiling and Biomarkers
  • OCT 29, 2014 6:00 AM PDT

    Expanding the scope of RNA-Seq to archival FFPE samples

    Kelli Bramlett, M.S.
    Research & Development Scientist, Thermo Fisher Scientific
    BIOGRAPHY
  • OCT 29, 2014 7:30 AM PDT

    Making Clinical NGS possible

    Vikram Devgan, PhD, MBA
    Senior Director, Spatial Genomics Business Unit, NanoString Technologies
    BIOGRAPHY
  • OCT 29, 2014 9:00 AM PDT

    What's wrong with biomarker development for cancer

    Anna Barker, PhD
    Co-Director, Complex Adaptive Systems Initiative, Director, Transformative Healthcare Networks, Professor, School of Life Sciences, Arizona State University (ASU)
    BIOGRAPHY
  • OCT 29, 2014 12:00 PM PDT

    Improving the Robustness and Reproducibility of Quantitative Proteomics

    Michael MacCoss, PhD
    Professor of Genome Sciences, University of Washington, School of Medicine
    BIOGRAPHY
  • OCT 29, 2014 1:30 PM PDT

    PDX Tumor Models for Oncology Research and Preclinical Prediction

    Walter Ausserer, PhD
    Business Unit Management, Senior Business Unit Manager, The Jackson Laboratory
    BIOGRAPHY
  • Drug-tailored, efficacy-predictive and prognostic biomarker approaches for proper patient selection
    OCT 29, 2014 3:00 PM PDT

    Drug-tailored, efficacy-predictive and prognostic biomarker approaches for proper patient selection

    Peter Blume-Jensen, MD, PhD
    Chief Scientific Officer, XTuit Pharmaceuticals, Inc.
    BIOGRAPHY
  • OCT 29, 2014 3:00 PM PDT

    Molecular Prognosis in the Management of Early Stage Lung Cancer

    Michael J Mann, MD
    Associate Professor of Surgery, Division of Adult Cardiothoracic Surgery, Chief of General Thoracic Surgery, University of California, San Francisco, VA Medical Center
    BIOGRAPHY
  • OCT 30, 2014 6:00 AM PDT

    A platform for combining the results of WES and RNA-seq analysis

    Naomi Thomson
    Director, Clinical Analytics and Workflow Products, CLC Bio, a Qiagen company
    BIOGRAPHY
  • OCT 30, 2014 10:30 AM PDT

    Development of molecularly targeted imaging agents and identification of novel targets in cancer

    Kimberly Kelly , PhD
    Associate Professor of Biomedical Engineering, University of Virginia
    BIOGRAPHY
  • OCT 30, 2014 1:30 PM PDT

    Structural Pathways of Cancer

    Ruth Nussinov, PhD
    Head, Computational Structural Biology Group, Senior Investigator, Center for Cancer Research, National Cancer Institute
    BIOGRAPHY
  • Clinical Proteomics
  • OCT 29, 2014 7:30 AM PDT

    Antibody-based Proteomics: Fast-Tracking Molecular Diagnostics and Target Discovery in Oncology

    Darran O'Connor, PhD
    Senior Lecturer, School of Biomolecular & Biomedical Science, Co-Director, Cancer Biology & Therapeutics Laboratory, University of Dublin
    BIOGRAPHY
  • Cancer Epigenetics
  • OCT 29, 2014 9:00 AM PDT

    Reading and disrupting the histone code with chemical agents: making new tools to understand epigenetic methylation pathways in stem-like cancers

    Fraser Hof, PhD
    Associate Professor, University of Victoria
    BIOGRAPHY
  • OCT 30, 2014 6:00 AM PDT

    Epigenetic Dysregulation in the Pathogenesis of Myeloproliferative Neoplasms

    Kristin Landis-Piwowar, PhD, MLS
    Assistant Professor, Biomedical Diagnostic & Therapeutic Sciences, , Oakland University
    BIOGRAPHY
  • Keynote
  • OCT 29, 2014 10:30 AM PDT

    Learning from the Pointillists - Using Big Data Approaches to Embrace the Complexity of Cancer

    Kenneth Buetow, PhD, FACMI
    Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
    BIOGRAPHY
  • OCT 30, 2014 7:30 AM PDT

    Challenges in biomarker testing in non-small cell lung cancer research

    Nicola Normanno, MD
    Director, Research Department, Centro di Ricerche Oncologiche di Mercogliano, Naples, Italy
    BIOGRAPHY
  • OCT 30, 2014 9:00 AM PDT

    A head-to-head comparison of whole blood derived samples (cfDNA vs CTC DNA) for cancer research using next-generation sequencing

    Paul W. Dempsey, PhD
    Chief Science Officer, Cynvenio
    BIOGRAPHY
  • Cancer Metabolism
  • OCT 29, 2014 12:00 PM PDT

    Obesity, weight loss, and the microenvironment in basal-like breast cancer

    Liza Makowski, PhD
    Assistant Professor, Nutrition, UNC Gillings School of Global Public Health
    BIOGRAPHY
  • OCT 29, 2014 1:30 PM PDT

    Protein phosphatase 2A in cell survival upon metabolic stress

    Mei Kong, PhD
    Assistant Professor, Cancer Biology , City of Hope National Medical Center
    BIOGRAPHY
  • OCT 30, 2014 12:00 PM PDT

    The metabolic microenvironment in tumors and its impact on T-cell mediated immunity

    Julian J. Lum, PhD
    Scientist BC Cancer Agency's Deeley Research Centre, Assistant Professor Department of Biochemistry and Microbiology, University of Victoria
    BIOGRAPHY
  • OCT 30, 2014 3:00 PM PDT

    Probing cancer metabolism using isotope tracers to identify therapeutic targets

    Christian Metallo, PhD
    Principal Investigator, Metallo Lab, Assistant Professor, Bioengineering, University of California, San Diego
    BIOGRAPHY
  • Therapeutics; Cancer Therapies & New Techniques
  • OCT 29, 2014 12:00 PM PDT

    A Next-Gen Sequencing Software Workflow for Cancer Gene Panel Analysis

    Kerri Phillips
    Clinical Research Product Manager, DNASTAR
    BIOGRAPHY
  • OCT 29, 2014 1:30 PM PDT

    Metabolic therapy for the adjuvant treatment of malignant brain tumors

    Adrienne C. Scheck, PhD
    Associate Professor, Neuro-Oncology Research, Barrow Brain Tumor Research Center, Barrow Neurological Institute
    BIOGRAPHY
  • OCT 29, 2014 3:00 PM PDT

    Transforming the future of oncology with genomics

    Jennifer Stone, PhD
    Senior Market Manager, Oncology , Illumina
    BIOGRAPHY
  • OCT 30, 2014 10:30 AM PDT

    Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy: A Tool for Optimizing Drug Management

    William Clarke, PhD, MBA, DABCC
    Associate Professor of Pathology, Clinical Toxicology, Director, Point-of-Care Testing, Johns Hopkins University School of Medicine
    BIOGRAPHY
  • OCT 30, 2014 12:00 PM PDT

    What is best practice for testing for unexpected pregnancy in pediatric and adult patients prior to cancer diagnostics, imaging and therapy?

    Sharon M. Geaghan, MD
    Chief, Pathology at Lucile Packard Children's Hospital at Stanford, Associate Professor in the Department of Pathology, Stanford University
    BIOGRAPHY
  • OCT 30, 2014 12:00 PM PDT

    Breast-Predict: Leveraging the Power of Systems Medicine Towards Personalized Cancer Therapy

    William M. Gallagher, BSc PhD CBiol MSB
    Chief Scientific Officer at OncoMark, Professor of Cancer Biology, University of Dublin
    BIOGRAPHY
  • Cell Signaling
  • OCT 30, 2014 1:30 PM PDT

    Dissecting cancer signaling pathways with chemical scalpels

    Nadya Tarasova, PhD
    Head, Synthetic Biologics Core, Cancer and Inflammation Program, Center for Cancer Research National Cancer Institute
    BIOGRAPHY

Speakers


  • Kenneth Buetow, PhD, FACMI

    Kenneth Buetow, PhD, FACMI

    Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University

    BIOGRAPHY
  • Darran O'Connor, PhD

    Darran O'Connor, PhD

    Senior Lecturer, School of Biomolecular & Biomedical Science, Co-Director, Cancer Biology & Therapeutics Laboratory, University of Dublin

    BIOGRAPHY
  • Nicola Normanno, MD

    Nicola Normanno, MD

    Director, Research Department, Centro di Ricerche Oncologiche di Mercogliano, Naples, Italy

    BIOGRAPHY
  • Paul W. Dempsey, PhD

    Paul W. Dempsey, PhD

    Chief Science Officer, Cynvenio

    BIOGRAPHY
  • John Carpten, PhD

    John Carpten, PhD

    Deputy Director of Basic Science, Professor and Director Integrated Cancer Genomics Division, TGen

    BIOGRAPHY
  • Josip Blonder, MD

    Josip Blonder, MD

    Senior Scientist, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research (FNLCR)

    BIOGRAPHY
  • Kristin Landis-Piwowar, PhD, MLS

    Kristin Landis-Piwowar, PhD, MLS

    Assistant Professor, Biomedical Diagnostic & Therapeutic Sciences, , Oakland University

    BIOGRAPHY
  • Julian J. Lum, PhD

    Julian J. Lum, PhD

    Scientist BC Cancer Agency's Deeley Research Centre, Assistant Professor Department of Biochemistry and Microbiology, University of Victoria

    BIOGRAPHY
  • Christian Metallo, PhD

    Christian Metallo, PhD

    Principal Investigator, Metallo Lab, Assistant Professor, Bioengineering, University of California, San Diego

    BIOGRAPHY
  • Naomi Thomson

    Naomi Thomson

    Director, Clinical Analytics and Workflow Products, CLC Bio, a Qiagen company

    BIOGRAPHY
  • Kimberly Kelly , PhD

    Kimberly Kelly , PhD

    Associate Professor of Biomedical Engineering, University of Virginia

    BIOGRAPHY
  • Ruth Nussinov, PhD

    Ruth Nussinov, PhD

    Head, Computational Structural Biology Group, Senior Investigator, Center for Cancer Research, National Cancer Institute

    BIOGRAPHY
  • William Clarke, PhD, MBA, DABCC

    William Clarke, PhD, MBA, DABCC

    Associate Professor of Pathology, Clinical Toxicology, Director, Point-of-Care Testing, Johns Hopkins University School of Medicine

    BIOGRAPHY
  • Sharon M. Geaghan, MD

    Sharon M. Geaghan, MD

    Chief, Pathology at Lucile Packard Children's Hospital at Stanford, Associate Professor in the Department of Pathology, Stanford University

    BIOGRAPHY
  • William M. Gallagher, BSc PhD CBiol MSB

    William M. Gallagher, BSc PhD CBiol MSB

    Chief Scientific Officer at OncoMark, Professor of Cancer Biology, University of Dublin

    BIOGRAPHY
  • Jennifer Stone, PhD

    Jennifer Stone, PhD

    Senior Market Manager, Oncology , Illumina

    BIOGRAPHY
  • Adrienne C. Scheck, PhD

    Adrienne C. Scheck, PhD

    Associate Professor, Neuro-Oncology Research, Barrow Brain Tumor Research Center, Barrow Neurological Institute

    BIOGRAPHY
  • Srinivas (Sri) Sridhar, PhD

    Srinivas (Sri) Sridhar, PhD

    Director, NSF IGERT Nanomedicine Science and Technology Program, Director, Electronic Materials Research Institute, Arts and Sciences Distinguished Professor of Physics, Lecturer on Radiation

    BIOGRAPHY
  • Katherine LB Borden, PhD

    Katherine LB Borden, PhD

    Principal Investigator, Structure and Function of the Cell Nucleus research unit, Full Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Instit

    BIOGRAPHY
  • Jonathan Shaffer, PhD, MBA

    Jonathan Shaffer, PhD, MBA

    Director, R&D, NGS Assay Technologies, QIAGEN

    BIOGRAPHY
  • Fraser Hof, PhD

    Fraser Hof, PhD

    Associate Professor, University of Victoria

    BIOGRAPHY
  • Liza Makowski, PhD

    Liza Makowski, PhD

    Assistant Professor, Nutrition, UNC Gillings School of Global Public Health

    BIOGRAPHY
  • Mei Kong, PhD

    Mei Kong, PhD

    Assistant Professor, Cancer Biology , City of Hope National Medical Center

    BIOGRAPHY
  • Kelli Bramlett, M.S.

    Kelli Bramlett, M.S.

    Research & Development Scientist, Thermo Fisher Scientific

    BIOGRAPHY
  • Vikram Devgan, PhD, MBA

    Vikram Devgan, PhD, MBA

    Senior Director, Spatial Genomics Business Unit, NanoString Technologies

    BIOGRAPHY
  • Anna Barker, PhD

    Anna Barker, PhD

    Co-Director, Complex Adaptive Systems Initiative, Director, Transformative Healthcare Networks, Professor, School of Life Sciences, Arizona State University (ASU)

    BIOGRAPHY
  • Michael MacCoss, PhD

    Michael MacCoss, PhD

    Professor of Genome Sciences, University of Washington, School of Medicine

    BIOGRAPHY
  • Walter Ausserer, PhD

    Walter Ausserer, PhD

    Business Unit Management, Senior Business Unit Manager, The Jackson Laboratory

    BIOGRAPHY
  • Peter Blume-Jensen, MD, PhD

    Peter Blume-Jensen, MD, PhD

    Chief Scientific Officer, XTuit Pharmaceuticals, Inc.

    BIOGRAPHY
  • Michael J Mann, MD

    Michael J Mann, MD

    Associate Professor of Surgery, Division of Adult Cardiothoracic Surgery, Chief of General Thoracic Surgery, University of California, San Francisco, VA Medical Center

    BIOGRAPHY
  • Kerri Phillips

    Kerri Phillips

    Clinical Research Product Manager, DNASTAR

    BIOGRAPHY
  • Nadya Tarasova, PhD

    Nadya Tarasova, PhD

    Head, Synthetic Biologics Core, Cancer and Inflammation Program, Center for Cancer Research National Cancer Institute

    BIOGRAPHY

Sponsors & Partners

For information on becoming a sponsor or exhibitor, please click here.


Program Committee

To download the Program Committee brochure here.


  • Alan Wright, MD

    Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

    See more See less
  • Vincent Mauro, Ph.D.

    Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

    See more See less
  • Paul Mathews

    Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ...

    See more See less
  • Tatjana Matejic

    Tatjana is an immunologist with more than two decades of experience working at biotech and pharma companies from start-ups to large global corporations ( Pfizer,Inc. being the latest), contributing significantly to team efforts and successes of more than thirty early and clinical ...

    See more See less
  • Mark Marzinke

    Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

    See more See less
  • Alan Maisel, MD

    Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

    See more See less
  • C Jimmy Lin, MD, PhD, MHS

    Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

    See more See less
  • Agnieszka Caruso

    Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

    See more See less
  • Kamisha Johnson-Davis, PhD, DABCC, FACB

    Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

    See more See less
  • Bruce Hollis, PhD

    Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

    See more See less
  • Michael Holick, MD, PhD

    Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

    See more See less
  • Ross J Molinaro, PhD, MT(ASCP), DABCC, FACB

    Ross J. Molinaro, PhD, MT(ASCP), DABCC, FACB is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University. He received his PhD in Clinical Chemistry and Molecular Medicine from Cleveland State University and completed the ComACC training ...

    See more See less
  • Howard Morris, PhD, FAACB, FFSc(RCPA)

    Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry ...

    See more See less
  • John Quackenbush

    John Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the Department of Biostatistics at the Harvard TH Chan School of Public Health and Professor at the Dana-Farber Cancer Institute. John's PhD was in Theoretical Physics but a fellowship to work ...

    See more See less
  • Stephanie Willerth, PhD

    Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

    See more See less
  • Bart C. Weimer, PhD

  • Sihe Wang

    Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

    See more See less
  • Katerina Venderova

    Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western ...

    See more See less
  • Theral Timpson

  • Deanne Taylor

    Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

    See more See less
  • Leigh Anne Swayne, PhD

  • Joely Straseski, PhD, MS, MT(ASCP), DABCC

    Dr. Straseski is a medical director of endocrinology at ARUP Laboratories and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a Master's degree in bacteriology from the University of ...

    See more See less
  • Ahmad Salehi

    Ahmad Salehi, M.D., Ph.D. is a Clinical Associate Professor at the Department of Psychiatry and Behavioral Sciences, Stanford Medical School and the Director of the Translational Laboratory at the VA Palo Alto Health Care System in California. He obtained his MD in Tehran, Iran ...

    See more See less
  • Amy K Saenger, PhD, DABCC, FACB

  • Ulrich Hengst

    Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the ...

    See more See less
  • Timothy Harris

    Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

    See more See less
  • Judd Moul

    Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

    See more See less
  • Ariel Louwrier

    President & CEO of StressMarq Biosciences Inc., a research reagent company with primary product lines in neurodegenerative diseases and cellular stress based in Victoria (BC), Canada. Successful Senior Scientific Business Executive with demonstrated expertise growing markets ...

    See more See less
  • Martin Latterich

    The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

    See more See less
  • Fred Russell Kramer, PhD

    Fred Russell Kramer currently works at the Department of Microbiology, Biochemistry and Molecular Genetics, at the Public Health Research Institute of the New Jersey Medical School at Rutgers University. His laboratory's current current project is the design of extremely ...

    See more See less
  • Daniel Irimia, MD, PhD

  • David Carpentieri

  • Peter Blume-Jensen

    Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.  From 2001 to 2008 Peter was department head at first Serono, US and ...

    See more See less
  • Josip Blonder

    Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

    See more See less
  • Antonio Baines

    Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

    See more See less
  • R. Claudio Aguilar, Ph.D.

    Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

    See more See less
  • Kathryn Wellen, PhD

  • Ottavio Arancio MD, Ph.D

    Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

    See more See less